Luis Buzón Martín (Luis Buzón-Martín, Luis Buzón, Luis Buzon-Martin)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 18

Top Topics

Men Who Have Sex With Men

Gestational Age

Hiv Infected Patients

Top Venues

The Journal of antimicrobial chemotherapy

Journal of clinical medicine

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Jesús Troya García, Guillermo Pousada, Rafael Micán, Carlos Galera, José Sanz, Ignacio de Los Santos, Carlos Dueñas, Noemí Cabello, Cristina Martín, María Josefa Galindo, María Ángeles Garcinuño, Roberto Pedrero-Tomé, Luis Buzón Martín
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96 weeks of RETROBIC Study. The Journal of antimicrobial chemotherapy 79 (3) (2024)
Jesús Troya García, Guillermo Pousada, Rafael Micán, Carlos Galera, José Sanz, Ignacio de Los Santos, Carlos Dueñas, Noemí Cabello, Cristina Martín, María Josefa Galindo, María Ángeles Garcinuño, Roberto Pedrero-Tomé, Luis Buzón Martín
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96 weeks of RETROBIC Study. The Journal of antimicrobial chemotherapy 79 (3) (2024)
Luis Buzón Martín, Carolina Navarro-San Francisco, María Fernandez-Regueras, Leticia Sanchez-Gomez
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature. The Journal of antimicrobial chemotherapy (2024)
Luis Buzón Martín, Carolina Navarro-San Francisco, María Fernandez-Regueras, Leticia Sanchez-Gomez
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Luis Buzón Martín, Jesús Troya García
Reasons against routine determination of plasma trough levels in PWH treated with intramuscular long acting cabotegravir and rilpivirine as of today. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2024)
Jesús Troya García, Guillermo Pousada, Rafael Micán, Carlos Galera, José Sanz, Ignacio de Los Santos, Carlos Dueñas, Noemí Cabello, Cristina Martín, María Josefa Galindo, María Ángeles Garcinuño, Roberto Pedrero-Tomé, Luis Buzón Martín
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96 weeks of RETROBIC Study. The Journal of antimicrobial chemotherapy 79 (3) (2024)
Luis Buzón Martín, Carolina Navarro-San Francisco, María Fernandez-Regueras, Leticia Sanchez-Gomez
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Luis Buzón Martín, Carolina Navarro-San Francisco, María Fernandez-Regueras, Leticia Sanchez-Gomez
Integrase strand transfer inhibitor resistance mediated by R263K plus E157Q in a patient with HIV infection treated with bictegravir/tenofovir alafenamide/emtricitabine: case report and review of the literature. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Jesús Troya García, Guillermo Pousada, Rafael Micán, Carlos Galera, José Sanz, Ignacio de Los Santos, Carlos Dueñas, Noemí Cabello, Cristina Martín, María Josefa Galindo, María Ángeles Garcinuño, Roberto Pedrero-Tomé, Luis Buzón Martín
Real-life data of immune recovery using bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people living with HIV. Results at 48-96 weeks of RETROBIC Study. The Journal of antimicrobial chemotherapy (2024)
Carlos Dueñas-Gutiérrez, Luis Buzón Martín, Roberto Pedrero-Tomé, José A Iribarren, Ignacio De Los Santos, Sara De la Fuente, Guillermo Pousada, Miguel Angel Moran, Estela Moreno, Eva Ferreira, Julia Gómez, Jesús Troya García
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV. Viruses 15 (4) (2023)
Jesús Troya García, Roberto Pedrero-Tomé, Luis Buzón Martín, Carlos Dueñas, null On Behalf Of The Spade Study Group
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV). Journal of clinical medicine 12 (3) (2023)
Jesús Troya García, Roberto Pedrero-Tomé, Luis Buzón Martín, Carlos Dueñas, null On Behalf Of The Spade Study Group
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV). Journal of clinical medicine 12 (3) (2023)
Jesús Troya García, Roberto Pedrero-Tomé, Luis Buzón Martín, Carlos Dueñas, null On Behalf Of The Spade Study Group
Predict the Effects of Dolutegravir (DTG) Plus Lamivudine (3TC) on Immunological Responses in People Living with HIV (PLWHIV). Journal of clinical medicine 12 (3) (2023)
Carlos Dueñas-Gutiérrez, Luis Buzón Martín, Roberto Pedrero-Tomé, José A Iribarren, Ignacio De Los Santos, Sara De la Fuente, Guillermo Pousada, Miguel Angel Moran, Estela Moreno, Eva Ferreira, Julia Gómez, Jesús Troya García
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV. Viruses 15 (4) (2023)
Carlos Dueñas-Gutiérrez, Luis Buzón Martín, Roberto Pedrero-Tomé, José A Iribarren, Ignacio De Los Santos, Sara De la Fuente, Guillermo Pousada, Miguel Angel Moran, Estela Moreno, Eva Ferreira, Julia Gómez, Jesús Troya García
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV. Viruses 15 (4) (2023)
Carlos Dueñas-Gutiérrez, Luis Buzón Martín, Roberto Pedrero-Tomé, José A Iribarren, Ignacio De Los Santos, Sara De la Fuente, Guillermo Pousada, Miguel Angel Moran, Estela Moreno, Eva Ferreira, Julia Gómez, Jesús Troya García
Efficacy and Safety of Two-Drug Regimens with Dolutegravir plus Rilpivirine or Lamivudine in HIV-1 Virologically Suppressed People Living with HIV. Viruses 15 (4) (2023)
Luis Buzón Martín, I Zollner-Schwetz, Selma Tobudic, Emilia Cercenado, Jaime Lora-Tamayo
Dalbavancin for the Treatment of Prosthetic Joint Infections: A Narrative Review. Antibiotics (Basel, Switzerland) 10 (6) (2021)
Luis Buzón Martín, Miguel Ángel Morán Rodríguez, Nicole Mercier, Maria Ortega Lafont, Eva Ojeda Fernández, Ana Ruiz de la Parte, Miguel Estefanía
Rhizopus arrhizus Invasive Infection due to Self-Inflicted Scratch Injuries in a Diabetic Patient with Non-ketotic Acidosis. Mycopathologia 182 (9-10) (2017)